ABOUT THIS FUND
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.
PRICE
$122.88 ▲ UP 1.56% (+$1.89)HOLDINGS
TOP 20 OF 27 · 82.48% OF THE FUNDRANK STOCK WEIGHT SHARES VALUE
